Working... Menu
Trial record 41 of 527 for:    "Primary Peritoneal Carcinoma"

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01570582
Recruitment Status : Unknown
Verified April 2012 by Taek Sang Lee, Korean Gynecologic Oncology Group.
Recruitment status was:  Active, not recruiting
First Posted : April 4, 2012
Last Update Posted : April 4, 2012
Information provided by (Responsible Party):
Taek Sang Lee, Korean Gynecologic Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2014
  Estimated Study Completion Date : March 2014